134 related articles for article (PubMed ID: 25503345)
1. Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.
Erdmann JI; Eskens FA; Vollmer CM; Kok NF; Groot Koerkamp B; Biermann K; van Eijck CH
Ann Surg Oncol; 2015 Jul; 22(7):2401-7. PubMed ID: 25503345
[TBL] [Abstract][Full Text] [Related]
2. Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater.
Chang MC; Chang YT; Sun CT; Chiu YF; Lin JT; Tien YW
World J Surg; 2007 May; 31(5):1135-41. PubMed ID: 17420962
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
Erdmann JI; Morak MJ; Duivenvoorden HJ; van Dekken H; Kazemier G; Kok NF; van Eijck CH
HPB (Oxford); 2015 Jul; 17(7):573-9. PubMed ID: 25800041
[TBL] [Abstract][Full Text] [Related]
4. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
[TBL] [Abstract][Full Text] [Related]
5. [Periampullary carcinoma or tumor of the ampulla of Vater?].
Vasilescu C; Herlea V; Stoicescu M
Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
8. Histological typing of pancreatic and periampullary carcinoma.
Klöppel G; Maillet B
Eur J Surg Oncol; 1991 Apr; 17(2):139-52. PubMed ID: 2015920
[TBL] [Abstract][Full Text] [Related]
9. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
Sellner FJ; Riegler FM; Machacek E
Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
[TBL] [Abstract][Full Text] [Related]
10. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
11. Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer.
Pomianowska E; Grzyb K; Westgaard A; Clausen OP; Gladhaug IP
Eur J Surg Oncol; 2012 Nov; 38(11):1043-50. PubMed ID: 22883964
[TBL] [Abstract][Full Text] [Related]
12. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
[TBL] [Abstract][Full Text] [Related]
13. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
14. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin.
Komine R; Kojima M; Ishi G; Kudo M; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Kobayashi T; Akimoto T; Murakami A; Sasaki M; Tanaka M; Matsuzaki A; Ohike N; Uchida K; Sugiyama T; Hirabayashi K; Tajiri T; Ishida K; Kai K; Omori Y; Notohara K; Yamaguchi H; Matsuda Y; Naito Y; Fukumura Y; Hamada Y; Mihara Y; Masugi Y; Gotohda N; Harada K; Fukushima N; Furukawa T
Cancer Med; 2021 Jun; 10(11):3499-3510. PubMed ID: 34008914
[TBL] [Abstract][Full Text] [Related]
15. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
18. High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas.
Jeong BK; Sung YN; Kim SJ; An S; Park H; Hwang HS; Kang HJ; Lee JH; Song KB; Kim KP; Hwang DW; Lee SS; Kim SC; Hong SM
Hum Pathol; 2019 Feb; 84():92-104. PubMed ID: 30261192
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the diagnosis and treatment of periampullary tumours.
Skórzewska M; Kurzawa P; Ciszewski T; Pelc Z; Polkowski WP
Surg Oncol; 2022 Sep; 44():101853. PubMed ID: 36152420
[TBL] [Abstract][Full Text] [Related]
20. [CT-guided percutaneous fine needle aspiration cytodiagnosis of pancreatic and periampullary tumors].
Jia ZG; Pan RQ; Liu DH
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):124-6. PubMed ID: 3652914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
